Elkhorn Partners’s Bausch Health BHC Stock Holding History

Elkhorn Partners’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,000	Closed	-$6K	–	44
2022 Q4	$6K	Hold	1,000	–	–	﹤0.01%	40
2022 Q3	$7K	Sell	1,000 -3,200	-76%	-$22.2K	0.01%	43
2022 Q2	$35K	Buy	+4,200	New	+$58.7K	0.02%	41

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Elkhorn Partners's BHC Position: Q1 2023 in Review

Elkhorn Partners sold out of Bausch Health (BHC) in Q1 2023, closing a stake of 1,000 shares — an estimated $6K sold.

Elkhorn Partners first reported a position in BHC in Q2 2022 and held it in 3 quarters. The position peaked at $35K in Q2 2022. 235 funds tracked by Wall St. Rank hold BHC as of Q1 2023.

Elkhorn Partners reported no remaining Bausch Health position as of Q1 2023 after selling out during the quarter.
Elkhorn Partners sold 1,000 Bausch Health shares in Q1 2023, an estimated $6K.
Elkhorn Partners first reported a position in Bausch Health in Q2 2022 and held it in 3 quarters.
Elkhorn Partners's Bausch Health position peaked at $35K in Q2 2022.
235 funds tracked by Wall St. Rank held Bausch Health as of Q1 2023.

Based on Elkhorn Partners's 13F filing for Q1 2023, filed 12 May 2023.